UC BON.CAP.CERT. 06/24 ZAL/ DE000HD2GTZ7 /
17/05/2024 21:46:33 | Var.-0.050 | Denaro21:59:15 | Lettera17/05/2024 | Sottostante | Prezzo di esercizio | Expiration date | Tipo di opzione |
---|---|---|---|---|---|---|---|
22.920EUR | -0.22% | 22.860 Quantità in denaro: 500 |
- Quantità in lettera: 6,000 |
ZALANDO SE | - - | 28/06/2024 | Call |
GlobeNewswire
23:39
IntelGenx Initiates Restructuring Proceedings Under the CCAA to Implement a Review of its Strategic ...
GlobeNewswire
23:15
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
Newsfile Corp
23:03
Experience the Illicit Romance of 19th-Century with B.D. Anderson's "Forbidden Desires"
GlobeNewswire
23:00
Altus Group Terminates Proposed Acquisition of Situs Group’s Commercial Real Estate Valuation Servic...
GlobeNewswire
23:00
Achilles Therapeutics Receives Nasdaq Deficiency Notice Regarding Minimum Bid Price Requirement
GlobeNewswire
22:48
AKRO Investor Alert: Kessler Topaz Meltzer & Check, LLP Urges Akero Therapeutics, Inc. Investors wit...
GlobeNewswire
22:42
MERGER INVESTIGATION ALERT: Kaskela Law LLC Announces Shareholder Investigation of Avangrid, Inc. (A...
GlobeNewswire
22:35
Breaking News: AthenaDexFi Launches Exciting Pre-Sale for ATH Token, Unveiling Lucrative Investment ...
GlobeNewswire
22:33
BriaCell Therapeutics Announces Closing of $5.0 Million Registered Direct Offering
GlobeNewswire
22:30
Nuvini (Nasdaq: NVNI) Announces Nasdaq Notification of Non-Compliance Regarding Delayed Form 20-F Fi...